Skip to main content

Peer Review reports

From: Major clinical benefit from adjuvant chemotherapy for stage II–III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis

Original Submission
18 Jan 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
27 Apr 2022 Reviewed Reviewer Report - Y. Kawaguchi
17 May 2022 Reviewed Reviewer Report
1 Jun 2022 Author responded Author comments - Jonas Kuon
Resubmission - Version 3
1 Jun 2022 Submitted Manuscript version 3
7 Jun 2022 Author responded Author comments - Jonas Kuon
Resubmission - Version 4
7 Jun 2022 Submitted Manuscript version 4
Publishing
10 Jun 2022 Editorially accepted
28 Jun 2022 Article published 10.1186/s12890-022-02043-6

You can find further information about peer review here.

Back to article page